Published in J Virol on January 01, 2000
The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site. EMBO J (2002) 2.41
Trypsin cleavage stabilizes the rotavirus VP4 spike. J Virol (2001) 1.68
Integrin alpha(v)beta(3) mediates rotavirus cell entry. Proc Natl Acad Sci U S A (2000) 1.56
Integrin-using rotaviruses bind alpha2beta1 integrin alpha2 I domain via VP4 DGE sequence and recognize alphaXbeta2 and alphaVbeta3 by using VP7 during cell entry. J Virol (2003) 1.56
Biochemical characterization of rotavirus receptors in MA104 cells. J Virol (2000) 1.52
Glycosphingolipid binding specificities of rotavirus: identification of a sialic acid-binding epitope. J Virol (2001) 1.51
Rotavirus architecture at subnanometer resolution. J Virol (2008) 1.48
Gene expression pattern in Caco-2 cells following rotavirus infection. J Virol (2002) 1.46
Beta1 integrin mediates internalization of mammalian reovirus. J Virol (2006) 1.43
Spike protein VP8* of human rotavirus recognizes histo-blood group antigens in a type-specific manner. J Virol (2012) 1.38
Heat shock cognate protein 70 is involved in rotavirus cell entry. J Virol (2002) 1.37
RhoA signaling is required for respiratory syncytial virus-induced syncytium formation and filamentous virion morphology. J Virol (2005) 1.36
Presence of host ICAM-1 in human immunodeficiency virus type 1 virions increases productive infection of CD4+ T lymphocytes by favoring cytosolic delivery of viral material. J Virol (2003) 1.24
NPXY motifs in the beta1 integrin cytoplasmic tail are required for functional reovirus entry. J Virol (2008) 1.18
Rotavirus VP8*: phylogeny, host range, and interaction with histo-blood group antigens. J Virol (2012) 1.18
Rotavirus activates JNK and p38 signaling pathways in intestinal cells, leading to AP-1-driven transcriptional responses and enhanced virus replication. J Virol (2006) 1.17
Listeria monocytogenes internalin B activates junctional endocytosis to accelerate intestinal invasion. PLoS Pathog (2010) 1.11
VLA-2 (alpha2beta1) integrin promotes rotavirus entry into cells but is not necessary for rotavirus attachment. J Virol (2002) 1.10
Interaction of rotaviruses with Hsc70 during cell entry is mediated by VP5. J Virol (2003) 1.08
Role of nucleolin in human parainfluenza virus type 3 infection of human lung epithelial cells. J Virol (2004) 1.07
Cholangiocyte expression of alpha2beta1-integrin confers susceptibility to rotavirus-induced experimental biliary atresia. Am J Physiol Gastrointest Liver Physiol (2008) 1.07
RGD tripeptide of bluetongue virus VP7 protein is responsible for core attachment to Culicoides cells. J Virol (2001) 1.06
Alpha4beta1 integrin acts as a cell receptor for murine polyomavirus at the postattachment level. J Virol (2003) 1.06
Rotavirus infection accelerates type 1 diabetes in mice with established insulitis. J Virol (2008) 0.99
Antibodies to rotavirus outer capsid glycoprotein VP7 neutralize infectivity by inhibiting virion decapsidation. J Virol (2002) 0.99
pH-induced conformational change of the rotavirus VP4 spike: implications for cell entry and antibody neutralization. J Virol (2005) 0.99
Integrin alpha3beta1 is an alternative cellular receptor for adenovirus serotype 5. J Virol (2003) 0.97
Reovirus uses multiple endocytic pathways for cell entry. J Virol (2012) 0.94
Monkey rotavirus binding to alpha2beta1 integrin requires the alpha2 I domain and is facilitated by the homologous beta1 subunit. J Virol (2003) 0.93
Effects on rotavirus cell binding and infection of monomeric and polymeric peptides containing alpha2beta1 and alphaxbeta2 integrin ligand sequences. J Virol (2004) 0.91
Rotavirus infection of infant and young adult nonobese diabetic mice involves extraintestinal spread and delays diabetes onset. J Virol (2007) 0.91
Crystallization and preliminary X-ray diffraction analysis of the sialic acid-binding domain (VP8*) of porcine rotavirus strain CRW-8. Acta Crystallogr Sect F Struct Biol Cryst Commun (2005) 0.91
Discrete domains within the rotavirus VP5* direct peripheral membrane association and membrane permeability. J Virol (2004) 0.89
Interactions of rotavirus VP4 spike protein with the endosomal protein Rab5 and the prenylated Rab acceptor PRA1. J Virol (2003) 0.89
Growth of rotaviruses in primary pancreatic cells. J Virol (2002) 0.88
VP7 mediates the interaction of rotaviruses with integrin alphavbeta3 through a novel integrin-binding site. J Virol (2004) 0.84
Integrin alphavbeta5 is a primary receptor for adenovirus in CAR-negative cells. Virol J (2010) 0.84
Cloning, expression, purification, crystallization and preliminary X-ray diffraction analysis of the VP8* carbohydrate-binding protein of the human rotavirus strain Wa. Acta Crystallogr Sect F Struct Biol Cryst Commun (2005) 0.83
Differential Effects of Escherichia coli Nissle and Lactobacillus rhamnosus Strain GG on Human Rotavirus Binding, Infection, and B Cell Immunity. J Immunol (2016) 0.83
Determinants of the specificity of rotavirus interactions with the alpha2beta1 integrin. J Biol Chem (2010) 0.80
Relative roles of GM1 ganglioside, N-acylneuraminic acids, and α2β1 integrin in mediating rotavirus infection. J Virol (2014) 0.79
Rotavirus activates lymphocytes from non-obese diabetic mice by triggering toll-like receptor 7 signaling and interferon production in plasmacytoid dendritic cells. PLoS Pathog (2014) 0.78
Rotavirus acceleration of type 1 diabetes in non-obese diabetic mice depends on type I interferon signalling. Sci Rep (2016) 0.78
Identification of Equine Lactadherin-derived Peptides That Inhibit Rotavirus Infection via Integrin Receptor Competition. J Biol Chem (2015) 0.77
Reconciliation of rotavirus temperature-sensitive mutant collections and assignment of reassortment groups D, J, and K to genome segments. J Virol (2011) 0.76
Characterization and Transferring of Human Rotavirus Double-Layered Particles in MA104 Cells. Jundishapur J Microbiol (2014) 0.76
Inflammatory and oxidative stress in rotavirus infection. World J Virol (2016) 0.76
Recombinant outer capsid glycoprotein (VP7) of rotavirus expressed in insect cells induces neutralizing antibodies in rabbits. Iran J Public Health (2012) 0.76
The SRL peptide of Rhesus Rotavirus VP4 protein governs cholangiocyte infection and the murine model of biliary atresia. Hepatology (2016) 0.75
Glycan Specificity of P[19] Rotavirus and Comparison with Those of Related P Genotypes. J Virol (2016) 0.75
Modeling of the rotavirus group C capsid predicts a surface topology distinct from other rotavirus species. Virology (2015) 0.75
Rhesus rotavirus VP6 regulates ERK-dependent calcium influx in cholangiocytes. Virology (2016) 0.75
Alteration of the thymic T cell repertoire by rotavirus infection is associated with delayed type 1 diabetes development in non-obese diabetic mice. PLoS One (2013) 0.75
A point mutation in the Rhesus rotavirus VP4 protein generated through rotavirus reverse genetics system attenuates the murine model of biliary atresia. J Virol (2017) 0.75
VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell (1990) 8.87
Identification of the rotaviral gene that codes for hemagglutination and protease-enhanced plaque formation. Virology (1983) 5.13
Proteolytic enhancement of rotavirus infectivity: molecular mechanisms. J Virol (1981) 4.87
The VLA protein family. Characterization of five distinct cell surface heterodimers each with a common 130,000 molecular weight beta subunit. J Biol Chem (1987) 4.47
The rhesus rotavirus gene encoding protein VP3: location of amino acids involved in homologous and heterologous rotavirus neutralization and identification of a putative fusion region. Proc Natl Acad Sci U S A (1988) 4.23
Biochemical and biophysical characteristics of diarrhea viruses of human and calf origin. J Virol (1975) 4.06
Isolation of human rotavirus in cell cultures: brief report. Arch Virol (1981) 3.83
Three-dimensional structure of rotavirus. J Mol Biol (1988) 3.79
Structural polypeptides of simian rotavirus SA11 and the effect of trypsin. J Virol (1981) 3.27
Molecular basis of rotavirus virulence: role of gene segment 4. J Virol (1986) 3.08
Three-dimensional structure of rhesus rotavirus by cryoelectron microscopy and image reconstruction. J Cell Biol (1990) 2.83
Neutralizing monoclonal antibodies to human rotavirus and indications of antigenic drift among strains from neonates. J Virol (1985) 2.81
Infectious rotavirus enters cells by direct cell membrane penetration, not by endocytosis. J Virol (1988) 2.72
Fibronectin receptor structures in the VLA family of heterodimers. Nature (1987) 2.54
Derivation of neutralizing monoclonal antibodies to human rotaviruses and evidence that an immunodominant neutralization site is shared between serotypes 1 and 3. Virology (1986) 2.34
Trypsin enhancement of rotavirus infectivity: mechanism of enhancement. J Virol (1981) 2.29
Adenovirus endocytosis via alpha(v) integrins requires phosphoinositide-3-OH kinase. J Virol (1998) 2.20
The minimal essential sequence for a major cell type-specific adhesion site (CS1) within the alternatively spliced type III connecting segment domain of fibronectin is leucine-aspartic acid-valine. J Biol Chem (1991) 2.08
Preliminary characterization of an epitope involved in neutralization and cell attachment that is located on the major bovine rotavirus glycoprotein. J Virol (1985) 1.97
Multiple activation states of VLA-4. Mechanistic differences between adhesion to CS1/fibronectin and to vascular cell adhesion molecule-1. J Biol Chem (1993) 1.92
Three-dimensional structure of the rotavirus haemagglutinin VP4 by cryo-electron microscopy and difference map analysis. EMBO J (1994) 1.90
Identification of a regulatory region of integrin beta 1 subunit using activating and inhibiting antibodies. J Biol Chem (1993) 1.83
Rotavirus contains integrin ligand sequences and a disintegrin-like domain that are implicated in virus entry into cells. Proc Natl Acad Sci U S A (1997) 1.82
Biochemical characterization of VLA-1 and VLA-2. Cell surface heterodimers on activated T cells. J Biol Chem (1985) 1.80
The rhesus rotavirus outer capsid protein VP4 functions as a hemagglutinin and is antigenically conserved when expressed by a baculovirus recombinant. J Virol (1989) 1.80
Identification of a tetrapeptide recognition sequence for the alpha 2 beta 1 integrin in collagen. J Biol Chem (1991) 1.79
Comparison of human, simian, and bovine rotaviruses for requirement of sialic acid in hemagglutination and cell adsorption. Virology (1989) 1.71
CD11c/CD18 on neutrophils recognizes a domain at the N terminus of the A alpha chain of fibrinogen. Proc Natl Acad Sci U S A (1991) 1.68
The function and distinctive regulation of the integrin VLA-3 in cell adhesion, spreading, and homotypic cell aggregation. J Biol Chem (1993) 1.59
Genetic mapping indicates that VP4 is the rotavirus cell attachment protein in vitro and in vivo. J Virol (1996) 1.56
Identification of group A rotavirus genes associated with virulence of a porcine rotavirus and host range restriction of a human rotavirus in the gnotobiotic piglet model. Virology (1995) 1.53
Identification in collagen type I of an integrin alpha2 beta1-binding site containing an essential GER sequence. J Biol Chem (1998) 1.51
Expression of mucosal homing receptor alpha4beta7 by circulating CD4+ cells with memory for intestinal rotavirus. J Clin Invest (1997) 1.51
Binding to sialic acids is not an essential step for the entry of animal rotaviruses to epithelial cells in culture. J Virol (1993) 1.50
Interchangeable alpha chain cytoplasmic domains play a positive role in control of cell adhesion mediated by VLA-4, a beta 1 integrin. J Exp Med (1993) 1.40
Structure and function of a ganglioside receptor for porcine rotavirus. J Virol (1998) 1.39
Regulation of in vitro capillary tube formation by anti-integrin antibodies. J Cell Biol (1993) 1.34
Alpha 4 beta 1 integrin-dependent cell adhesion is regulated by a low affinity receptor pool that is conformationally responsive to ligand. J Biol Chem (1995) 1.33
Divalent cations and ligands induce conformational changes that are highly divergent among beta1 integrins. J Biol Chem (1998) 1.33
Identification of putative ligand-binding sites of the integrin alpha 4 beta 1 (VLA-4, CD49d/CD29) Biochem J (1995) 1.32
Attachment of SA-11 rotavirus to erythrocyte receptors. Infect Immun (1980) 1.31
Identification of a novel recognition sequence for the integrin alpha 4 beta 1 in the COOH-terminal heparin-binding domain of fibronectin. EMBO J (1991) 1.31
Human enterocyte (Caco-2) migration is modulated in vitro by extracellular matrix composition and epidermal growth factor. J Clin Invest (1992) 1.30
Multiple functional forms of the integrin VLA-2 can be derived from a single alpha 2 cDNA clone: interconversion of forms induced by an anti-beta 1 antibody. J Cell Biol (1993) 1.26
Interactions between the two surface proteins of rotavirus may alter the receptor-binding specificity of the virus. J Virol (1996) 1.22
Integrins and human intestinal cell functions. Front Biosci (1999) 1.19
The memory B cell subset responsible for the secretory IgA response and protective humoral immunity to rotavirus expresses the intestinal homing receptor, alpha4beta7. J Immunol (1998) 1.19
Unmasking of intestinal epithelial lateral membrane beta1 integrin consequent to transepithelial neutrophil migration in vitro facilitates inv-mediated invasion by Yersinia pseudotuberculosis. Infect Immun (1997) 1.18
Identification of putative ligand binding sites within I domain of integrin alpha 2 beta 1 (VLA-2, CD49b/CD29) J Biol Chem (1994) 1.14
Induced cell surface expression of functional alpha 2 beta 1 integrin during megakaryocytic differentiation of K562 leukemic cells. Exp Cell Res (1992) 1.14
Role of the alpha subunit cytoplasmic domain in regulation of adhesive activity mediated by the integrin VLA-2. J Biol Chem (1993) 1.08
Mapping the hemagglutination domain of rotaviruses. J Virol (1995) 1.07
Expression of surface markers on alveolar macrophages from symptomatic patients with HIV infection as detected by flow cytometry. Chest (1994) 1.02
Role of integrin expression in adenovirus-mediated gene delivery to the intestinal epithelium. Hum Gene Ther (1998) 0.98
Cell lines susceptible to infection are permeabilized by cleaved and solubilized outer layer proteins of rotavirus. J Gen Virol (1997) 0.98
Multiple ligand binding functions for VLA-2 (alpha 2 beta 1) and VLA-3 (alpha 3 beta 1) in the integrin family. Cell Differ Dev (1990) 0.94
Serotypic characterization of outer capsid spike protein VP4 of vervet monkey rotavirus SA11 strain. Arch Virol (1998) 0.93
NPXY motifs control the recruitment of the alpha5beta1 integrin in focal adhesions independently of the association of talin with the beta1 chain. J Cell Sci (1997) 0.91
VLA-2 is a collagen receptor on endothelial cells. Immunol Cell Biol (1991) 0.88
Characterisation of G serotype dependent non-antibody inhibitors of rotavirus in normal mouse serum. Arch Virol (1998) 0.86
Atherosclerotic aortic gangliosides enhance integrin-mediated platelet adhesion to collagen. Arterioscler Thromb Vasc Biol (1999) 0.79
Characterization of SA-11 rotavirus receptorial structures on human colon carcinoma cell line HT-29. J Med Virol (1995) 0.79
VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell (1990) 8.87
Nrl is required for rod photoreceptor development. Nat Genet (2001) 5.68
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol (1999) 5.65
Antigenic mapping of the surface proteins of rhesus rotavirus. Virology (1986) 3.80
Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat Med (2001) 3.69
Simple and specific enzyme immunoassay using monoclonal antibodies for serotyping human rotaviruses. J Clin Microbiol (1987) 3.54
Characterization of the cell surface heterodimer VLA-4 and related peptides. J Biol Chem (1987) 2.94
Neutralizing monoclonal antibodies to human rotavirus and indications of antigenic drift among strains from neonates. J Virol (1985) 2.81
Activated conformations of very late activation integrins detected by a group of antibodies (HUTS) specific for a novel regulatory region (355-425) of the common beta 1 chain. J Biol Chem (1996) 2.72
Fibronectin receptor structures in the VLA family of heterodimers. Nature (1987) 2.54
Flow-cytometric separation and enrichment of hepatic progenitor cells in the developing mouse liver. Hepatology (2000) 2.43
Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells. J Virol (1996) 2.38
Uveal effusion syndrome: clinical features, surgical treatment, histologic examination of the sclera, and pathophysiology. Ophthalmology (2000) 2.36
Derivation of neutralizing monoclonal antibodies to human rotaviruses and evidence that an immunodominant neutralization site is shared between serotypes 1 and 3. Virology (1986) 2.34
Multiple very late antigen (VLA) heterodimers on platelets. Evidence for distinct VLA-2, VLA-5 (fibronectin receptor), and VLA-6 structures. J Biol Chem (1988) 2.20
Detection and characterization of novel rotavirus strains in the United States. J Clin Microbiol (1998) 2.16
The very late antigen family of heterodimers is part of a superfamily of molecules involved in adhesion and embryogenesis. Proc Natl Acad Sci U S A (1987) 2.11
Distinct functions of integrin alpha and beta subunit cytoplasmic domains in cell spreading and formation of focal adhesions. J Cell Biol (1993) 2.08
Accumulation of GTP-bound RhoA during cytokinesis and a critical role of ECT2 in this accumulation. J Biol Chem (2000) 2.04
Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism. J Neurochem (1991) 2.01
Treatment of gallbladder cancer by radical resection. Br J Surg (1999) 1.88
In vitro and in vivo consequences of VLA-2 expression on rhabdomyosarcoma cells. Science (1991) 1.85
Structure of the integrin VLA-4 and its cell-cell and cell-matrix adhesion functions. Immunol Rev (1990) 1.83
Identification of mutations associated with peroxisome-to-mitochondrion mistargeting of alanine/glyoxylate aminotransferase in primary hyperoxaluria type 1. J Cell Biol (1990) 1.78
Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma. Oncogene (2006) 1.68
Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes. Diabetes (2000) 1.67
Variation in neutralization epitopes of human rotaviruses in relation to genomic RNA polymorphism. Virology (1987) 1.64
The function and distinctive regulation of the integrin VLA-3 in cell adhesion, spreading, and homotypic cell aggregation. J Biol Chem (1993) 1.59
Radical resection of hilar bile duct carcinoma and predictors of survival. Br J Surg (2000) 1.57
Comparison of serum and mucosal antibody responses following severe acute rotavirus gastroenteritis in young children. J Clin Microbiol (1988) 1.55
RGD-independent binding of integrin alpha9beta1 to the ADAM-12 and -15 disintegrin domains mediates cell-cell interaction. J Biol Chem (2000) 1.53
Long-term outcome of adult-to-adult living donor liver transplantation for post-Kasai biliary atresia. Am J Transplant (2006) 1.53
Altered rate of fibronectin matrix assembly by deletion of the first type III repeats. J Cell Biol (1996) 1.49
Requirement for natural killer T (NKT) cells in the induction of allograft tolerance. Proc Natl Acad Sci U S A (2001) 1.48
Casting behavior of titanium alloys in a centrifugal casting machine. Biomaterials (2003) 1.48
Changing ligand specificities of alphavbeta1 and alphavbeta3 integrins by swapping a short diverse sequence of the beta subunit. J Biol Chem (1997) 1.45
Serotonin as a factor involved in pathophysiology of thromboangiitis obliterans. Int Angiol (1993) 1.40
Characteristics of hepatic alanine-glyoxylate aminotransferase in different mammalian species. Biochem J (1978) 1.40
Correlations between platelet aggregation, fibrinolysis, peripheral and central serotonergic measures in subhuman primates. Atherosclerosis (1994) 1.39
Long-term results of donor-specific blood transfusion with cyclosporine in living related kidney transplantation. Nephron (2001) 1.39
Inhibition of cell cycle progression by the alternatively spliced integrin beta 1C. Science (1995) 1.38
Experience with an enzyme immunoassay for serotyping human group A rotaviruses. J Clin Microbiol (1989) 1.36
Specific interaction of the recombinant disintegrin-like domain of MDC-15 (metargidin, ADAM-15) with integrin alphavbeta3. J Biol Chem (1998) 1.35
Characteristics and location of cross-reactive and serotype-specific neutralization sites on VP7 of human G type 9 rotaviruses. Virology (1993) 1.33
Demonstration of an immunodominant neutralization site by analysis of antigenic variants of SA11 rotavirus. J Virol (1985) 1.33
Specific interaction of angiostatin with integrin alpha(v)beta(3) in endothelial cells. J Biol Chem (2001) 1.32
Identification of putative ligand-binding sites of the integrin alpha 4 beta 1 (VLA-4, CD49d/CD29) Biochem J (1995) 1.32
Urokinase-type plasminogen activator receptor (CD87) is a ligand for integrins and mediates cell-cell interaction. J Biol Chem (2000) 1.31
Regulation of integrin function: evidence that bivalent-cation-induced conformational changes lead to the unmasking of ligand-binding sites within integrin alpha5 beta1. Biochem J (1998) 1.29
Increased procoagulant and antifibrinolytic activities in the lungs with idiopathic pulmonary fibrosis. Thromb Res (1995) 1.28
Augmented acetylcholine-induced, Rho-mediated Ca2+ sensitization of bronchial smooth muscle contraction in antigen-induced airway hyperresponsive rats. Br J Pharmacol (1999) 1.28
Amino acid residues in the alpha IIb subunit that are critical for ligand binding to integrin alpha IIbbeta 3 are clustered in the beta-propeller model. J Biol Chem (2001) 1.27
Direct binding of collagen to the I domain of integrin alpha 2 beta 1 (VLA-2, CD49b/CD29) in a divalent cation-independent manner. J Biol Chem (1994) 1.27
Significance of des-gamma-carboxy prothrombin in selection criteria for living donor liver transplantation for hepatocellular carcinoma. Am J Transplant (2009) 1.27
Interaction of integrins alpha 3 beta 1 and alpha 2 beta 1: potential role in keratinocyte intercellular adhesion. J Cell Biol (1993) 1.26
Multiple discontinuous ligand-mimetic antibody binding sites define a ligand binding pocket in integrin alpha(IIb)beta(3). J Biol Chem (2000) 1.25
Critical threonine and aspartic acid residues within the I domains of beta 2 integrins for interactions with intercellular adhesion molecule 1 (ICAM-1) and C3bi. J Biol Chem (1995) 1.23
Reactivities of serotyping monoclonal antibodies with culture-adapted human rotaviruses. J Clin Microbiol (1991) 1.22
Cellular interaction of integrin alpha3beta1 with laminin 5 promotes gap junctional communication. J Cell Biol (1998) 1.22
Peroxisomal localization of alanine: glyoxylate aminotransferase in human liver. Arch Biochem Biophys (1979) 1.22
The introduction of microvascular surgery to hepatic artery reconstruction in living-donor liver transplantation--its surgical advantages compared with conventional procedures. Transplantation (1992) 1.20
Highly divergent sequences of the pollen self-incompatibility (S) gene in class-I S haplotypes of Brassica campestris (syn. rapa) L. FEBS Lett (2000) 1.19
Shear stress inhibits adhesion of cultured mouse endothelial cells to lymphocytes by downregulating VCAM-1 expression. Am J Physiol (1994) 1.19
Critical amino acid residues for ligand binding are clustered in a predicted beta-turn of the third N-terminal repeat in the integrin alpha 4 and alpha 5 subunits. EMBO J (1995) 1.18
Transposon mutagenesis by Tn4560 and applications with avermectin-producing Streptomyces avermitilis. J Bacteriol (1993) 1.17
Human parechovirus 1 utilizes integrins alphavbeta3 and alphavbeta1 as receptors. J Virol (2000) 1.16
Molecular basis of ligand recognition by integrin alpha5beta 1. II. Specificity of arg-gly-Asp binding is determined by Trp157 OF THE alpha subunit. J Biol Chem (2000) 1.15
Mechanisms of integrin-mediated virus attachment and internalization process. Crit Rev Immunol (2001) 1.15
Ischemic preconditioning of the liver in rats: implications of heat shock protein induction to increase tolerance of ischemia-reperfusion injury. J Lab Clin Med (1996) 1.14
Identification of putative ligand binding sites within I domain of integrin alpha 2 beta 1 (VLA-2, CD49b/CD29) J Biol Chem (1994) 1.14
Tissue Doppler-derived index of left ventricular filling pressure, E/E', predicts survival of patients with non-valvular atrial fibrillation. Heart (2006) 1.13
Randomised phase III trial of irinotecan combined with cisplatin for advanced non-small-cell lung cancer. Br J Cancer (2003) 1.12
Phase II study of irinotecan combined with cisplatin in patients with previously untreated small-cell lung cancer. West Japan Lung Cancer Group. J Clin Oncol (1998) 1.12
ADAM 23/MDC3, a human disintegrin that promotes cell adhesion via interaction with the alphavbeta3 integrin through an RGD-independent mechanism. Mol Biol Cell (2000) 1.12
Induction of experimental bone metastasis in mice by transfection of integrin alpha 4 beta 1 into tumor cells. Am J Pathol (1996) 1.12
Anti-cancer drugs and glutathione stimulate vanadate-induced trapping of nucleotide in multidrug resistance-associated protein (MRP). FEBS Lett (1997) 1.11
Inhibition of the classical and alternative pathways by amino acids and their derivatives. Immunology (1978) 1.11
Lymphokine-like factors produced by human lymphoid cell lines with B or T cell surface markers. J Immunol (1976) 1.09
G3P2 rotaviruses causing diarrhoeal disease in neonates differ in VP4, VP7 and NSP4 sequence from G3P2 strains causing asymptomatic neonatal infection. Arch Virol (1996) 1.09
Cloning of large DNA fragments, which hybridize with actinorhodin biosynthesis genes, from kalafungin and nanaomycin A methyl ester producers and identification of genes for kalafungin biosynthesis of the kalafungin producer. J Antibiot (Tokyo) (1991) 1.09
Selective hemi-portocaval shunt based on portal vein pressure for small-for-size graft in adult living donor liver transplantation. Am J Transplant (2008) 1.08
Genes encoding two isocitrate dehydrogenase isozymes of a psychrophilic bacterium, Vibrio sp. strain ABE-1. J Bacteriol (1993) 1.08
Regulation of conformation and ligand binding function of integrin alpha5beta1 by the beta1 cytoplasmic domain. J Biol Chem (1996) 1.08
Phase I-II study of amrubicin and cisplatin in previously untreated patients with extensive-stage small-cell lung cancer. Ann Oncol (2005) 1.08
Rapid, specific and active site-catalyzed effect of tissue-plasminogen activator on hippocampus-dependent learning in mice. Neuroscience (2002) 1.07
Characterization and expression of a P-450-like mycinamicin biosynthesis gene using a novel Micromonospora-Escherichia coli shuttle cosmid vector. Mol Gen Genet (1994) 1.07
Identification of amino acid sequences in fibrinogen gamma -chain and tenascin C C-terminal domains critical for binding to integrin alpha vbeta 3. J Biol Chem (2000) 1.06
Subcellular distribution of pyruvate (glyoxylate) aminotransferases in rat liver. Biochem J (1978) 1.06
The urokinase type of plasminogen activator in cancer of digestive tracts. Thromb Res (1988) 1.06
Comparative sensitivities of solid-phase immune electron microscopy and enzyme-linked immunosorbent assay for serotyping of human rotavirus strains with neutralizing monoclonal antibodies. J Clin Microbiol (1988) 1.05
Subcellular distribution, and physical and immunological properties of hepatic alanine: glyoxylate aminotransferase isoenzymes in different mammalian species. Comp Biochem Physiol B (1982) 1.05
Critical residues of integrin alphaIIb subunit for binding of alphaIIbbeta3 (glycoprotein IIb-IIIa) to fibrinogen and ligand-mimetic antibodies (PAC-1, OP-G2, and LJ-CP3). J Biol Chem (1996) 1.05
Biphasic pattern of thymus regeneration after whole-body irradiation. J Exp Med (1969) 1.05
Degradation of uric acid to urea and glyoxylate in peroxisomes. J Biol Chem (1979) 1.05
Rotavirus antigenicity is affected by the genetic context and glycosylation of VP7. Virology (1995) 1.04
Critical residues for ligand binding in an I domain-like structure of the integrin beta1 subunit. J Biol Chem (1996) 1.04
Negative transcriptional regulation of the VCAM-1 gene by fluid shear stress in murine endothelial cells. Am J Physiol (1997) 1.04
Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1. Thromb Haemost (1990) 1.04
Involvement of beta2-microglobulin and integrin alphavbeta3 molecules in the coxsackievirus A9 infectious cycle. J Gen Virol (1999) 1.04